Business Context and Reporting Period
This Form 8-K is filed by ADVENTRX Pharmaceuticals, Inc. (not Savara Inc.) on November 15, 2004. The report discloses the issuance of a press release regarding financial results for the third fiscal quarter ended September 30, 2004. The registrant is incorporated in Delaware with principal executive offices in San Diego, California.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the press release furnished as Exhibit 99.1, which is incorporated by reference but not included in the provided text.
Material Changes
The filing does not explicitly detail material changes versus the prior comparable period. It serves solely as a notification that the third-quarter results have been announced via a press release.
Guidance, Outlook, and Risks
The provided text contains no management commentary, forward-looking guidance, risk factors, contingencies, or unusual items. Such information, if present, would be located in the referenced Exhibit 99.1 press release.
Investor Verification Checklist
- Verify the correct registrant name is ADVENTRX Pharmaceuticals, Inc., as the input metadata incorrectly listed "Savara Inc."
- Retrieve and review Exhibit 99.1 (Press Release dated November 15, 2004) to obtain actual financial figures for the quarter ended September 30, 2004.
- Confirm the company's current status, as the filing date is historical (2004).